Consolidated Statements of Cash Flows (Unaudited) (USD $)	12 Months Ended		151 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss before non-controlling interest	$ (1,837,803)	$ (627,460)	$ (9,845,229)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for prepayment	73,732		73,732
Amortized interest on warrants	3,017		3,017
Depreciation and amortization			132,077
Impairment loss			336,773
Inventory write-down			24,820
Impairment of related party receivables			35,383
Operating expenses paid by reducing note receivable			10,000
Stock issued for services	434,300	32,294	1,408,937
Deferred compensation			10,417
Stock issued for loan fees			423,000
Stock options issued for services			60,370
Legal fees forgiven			(12,296)
Debts forgiven			(302,891)
Provision for common stock subscription receivable			89,468
Amount attributable to non-controlling interest			33,000
Beneficial conversion of debt and accrued interest	536,895		770,275
Changes in assets and liabilities:
Interest receivable			(19,986)
Inventory			(24,820)
Prepaid Expenses	(73,253)	(6,667)	(79,920)
Other assets			(24,000)
Litigation settlement			100,000
Accounts payable and accrued expenses	219,694	179,997	1,834,313
Accrued expenses, related party	178,289	189,851	1,324,954
Net cash (used in) operating activities	(465,129)	(231,984)	(3,626,310)
CASH FLOWS FROM INVESTING ACTIVITIES:
Notes receivable from officer			(45,048)
Collection of notes receivable from officer			35,048
Notes receivable, related parties			(50,000)
Collection of notes receivable, related parties			50,000
Investment in property and equipment			(18,879)
Investment in film costs			(133,005)
Investment in web site development costs			(292,968)
Net cash (used in) investing activities			(454,852)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock			1,254,154
Payment of offering costs			(66,450)
Proceeds from notes payable	115,134	217,000	1,562,172
Proceeds from notes payable, related party	18,877	37,939	686,496
Payments of notes payable			(201,916)
Payments of notes payable, related party	(18,084)	(23,540)	(420,296)
Proceeds from issuance of convertible notes	350,000		1,267,800
Net cash provided by financing activities	465,927	231,399	4,081,960
NET INCREASE (DECREASE) IN CASH AND EQUIVALENTS	798	(585)	798
CASH AND EQUIVALENTS, Beginning of period	1	586
CASH AND EQUIVALENTS, End of period	799	1	799
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for: Interest paid			21,511
Cash paid during the period for: Income taxes paid			4,000
NONCASH FINANCING ACTIVITIES:
Beneficial conversion of debt and accrued interest	536,895		770,275
Stock issued for services	434,300	32,294	1,408,937
Stock issued for loan fees			423,000
Stock options issued for services			$ 60,370

GLOBAL HEALTH VOYAGER INC 10-K/A